USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$9.85B
Market Cap
22.92
P/E Ratio
5.93
EPS
$262.87
52 Week High
$127.70
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $2.8B |
Total Revenue | $4B |
Cost Of Revenue | $1.2B |
Costof Goods And Services Sold | $1.2B |
Operating Income | $608M |
Selling General And Administrative | $1.6B |
Research And Development | $364M |
Operating Expenses | $2.2B |
Investment Income Net | - |
Net Interest Income | $20M |
Interest Income | $20M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $145M |
Income Before Tax | $609M |
Income Tax Expense | $188M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $421M |
Comprehensive Income Net Of Tax | - |
Ebit | $672M |
Ebitda | $817M |
Net Income | $421M |
Field | Value (USD) |
---|---|
Total Assets | $6.2B |
Total Current Assets | $2.5B |
Cash And Cash Equivalents At Carrying Value | $1B |
Cash And Short Term Investments | $1B |
Inventory | $254M |
Current Net Receivables | $1B |
Total Non Current Assets | $3.7B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $103M |
Intangible Assets Excluding Goodwill | $103M |
Goodwill | $443M |
Investments | - |
Long Term Investments | $0 |
Short Term Investments | $0 |
Other Current Assets | $165M |
Other Non Current Assets | - |
Total Liabilities | $2.4B |
Total Current Liabilities | $2B |
Current Accounts Payable | $109M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $62M |
Total Non Current Liabilities | $325M |
Capital Lease Obligations | $119M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $119M |
Other Current Liabilities | $440M |
Other Non Current Liabilities | $140M |
Total Shareholder Equity | $3.9B |
Treasury Stock | - |
Retained Earnings | $2.5B |
Common Stock | $7K |
Common Stock Shares Outstanding | $75M |
Field | Value (USD) |
---|---|
Operating Cashflow | $738M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $145M |
Capital Expenditures | $116M |
Change In Receivables | - |
Change In Inventory | $25M |
Profit Loss | - |
Cashflow From Investment | -$255M |
Cashflow From Financing | -$356M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$353M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $421M |
Field | Value (USD) |
---|---|
Gross Profit | $2.8B |
Total Revenue | $4B |
Cost Of Revenue | $1.2B |
Costof Goods And Services Sold | $1.2B |
Operating Income | $608M |
Selling General And Administrative | $1.6B |
Research And Development | $364M |
Operating Expenses | $2.2B |
Investment Income Net | - |
Net Interest Income | $20M |
Interest Income | $20M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $145M |
Income Before Tax | $609M |
Income Tax Expense | $188M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $421M |
Comprehensive Income Net Of Tax | - |
Ebit | $672M |
Ebitda | $817M |
Net Income | $421M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Align Technology is a manufacturer of 3D digital scanners and the Invisalign clear aligners used in orthodontics. It is headquartered in San Jose, California.